Acknowledgments
This research was funded by High Plains Nutrition, LLC with a contribution from Friends of Hemp, Inc., a non-profit
hemp organization. The author wishes to thank Dr. Volker Bornemann and
his team at Avazyme, Inc., for the development of the low-LOQ testing
method and the analytical work on the data used in this study. Also, the
author thanks Dr. Manisha Das at the FDA-CVM for reviewing the testing
protocol and technical procedures used in the analytical testing.
Finally, the author wants to thank all those participating in the
process, reviewing this paper, and giving their thoughtful feedback.
Table
7: Phase 1 (untrimmed) data with outliers highlighted